Visscher TL, Seidell JC, Molarius A, van der Kuip D, Hofman A, Witteman JC
GLP-1R agonists effects on cardiovascular events The first pieces of evidence of the potential clinical benefit of GLP-1 agonists have emerged recently, pointing to a decrease of major adverse cardiovascular and cerebrovascular events (MACCE) including stroke, MI, cardiac mortality, acute coronary syndrome, and revascularization procedures
Good options include negimaki (thinly sliced meat wrapped around scallions or asparagus) and yakitori (grilled chicken skewers)
However, as the use of semaglutide has become more widespread, questions have arisen about its potential impact on the menstrual cycle in women
This week is key to reinforcing positive, healthy habits to continue building results long after injections end